Skip to content
TrialScanner

NCT02905318

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2Active, not recruitingPFECollaborator

Registry record

Lead sponsor
Canadian Cancer Trials Group
Conditions
Prostate Cancer
Primary completion
Apr 29, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02905318 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02905318: Palbociclib in Patients With... | TrialScanner